ERBB2 and ovarian carcinoma: It demonstrated that the combination of samfenet with NK cells exhibited a synergistic ADCC effect and significantly inhibited a HER2-overexpressing ovarian cancer patient-derived tumor xenograft (PDTX) in vivo model.